Examining the effect of lidocaine in abdominal surgery

The effect of lidocaine injection at FU's subcutaneous needling point on pain after abdominal surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240525061885N1

Enrollment

Registered

2024-06-13

Start date

2024-07-06

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after surgery. Abdominal and pelvic pain

Interventions

Intervention 1: Intervention group: 1 cc of 2% lidocaine (lidocaine hydrochloride 100 mg) is injected subcutaneously at the FU point. Intervention 2: Control group: 1 cc of distilled water is injected

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with ASA status one or two Age 20 to 65 years Elective abdominal surgery No addiction to drugs and alcohol Surgery duration 4 hours Informed consent of the patient

Exclusion criteria

Exclusion criteria: Abnormal bleeding Unusual complications during surgery Cardiac and respiratory arrest during abdominal surgery medical allergy

Design outcomes

Primary

Measure	Time frame
Improvement after abdominal surgeryhospitalization. Timepoint: at 6, 12 and 24 hours after the operation. Method of measurement: Using a visual analog scale ( VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGelare Shahabpur

Islamic Azad University

GelareShahabpur@gmail.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026